Cardiometabolic Care-team Integration Improves Outcomes in Diabetes
1 other identifier
observational
475
0 countries
N/A
Brief Summary
A pragmatic, quasi-experimental (non-randomized) design was used to evaluate clinical and cost outcomes among patients with type 1 or 2 diabetes (T1D or T2D) at two primary care clinics (n=1 intervention, n=1 usual care) between March 2012 and September 2014. At the intervention clinic, the 12-month Cardio-metabolic Care-Team Intervention (CMC-TI) was delivered to all qualifying patients; surveys were administered to evaluate relevant patient-reported outcomes over 12 months, and a process evaluation gauged CMC-TI feasibility and satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2012
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2014
CompletedFirst Submitted
Initial submission to the registry
June 2, 2018
CompletedFirst Posted
Study publicly available on registry
June 19, 2018
CompletedDecember 9, 2022
December 1, 2022
2.6 years
June 2, 2018
December 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c
Change in HbA1c between Intervention and Comparator sites
12 months
Secondary Outcomes (3)
Hospital/ER costs
12 months
LDL
12 months
Blood pressure
12 months
Study Arms (2)
CMC-TI
Cardiometabolic Care Team Intervention
Non-Intervention Comparator site
Non intervention comparator site with usual care
Interventions
The CMC-TI team included a registered nurse/certified diabetes educator (RN/CDE) Care Manager, medical assistant (MA) Health Coach, and RN Depression Care Manager. Decision support tools guided therapy for glucose, BP, low-density lipoprotein cholesterol (LDL-c), and depression. At the intervention clinic, the 12-month CMC-TI was delivered to all qualifying patients; surveys were administered to evaluate relevant patient-reported outcomes over 12 months.
Eligibility Criteria
\- All patients with type 1 and type 2 diabetes within two primary care clinics at Scripps Coastal Medical Group.
You may qualify if:
- All patients with type 1 and type 2 diabetes
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Corporate Vice President
Study Record Dates
First Submitted
June 2, 2018
First Posted
June 19, 2018
Study Start
March 1, 2012
Primary Completion
September 30, 2014
Study Completion
December 30, 2014
Last Updated
December 9, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share